Observational Study on the Patients With Pain Medications
1 other identifier
observational
2,636
0 countries
N/A
Brief Summary
The purpose of this study is to describe the use of pain treatments in Taiwan, the demographics, clinical characteristics of patients requiring pain treatments, current treatments, outcomes of treatments and the reasons for changing pain medication during treatment.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Oct 2007
Shorter than P25 for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2007
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2008
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2008
CompletedFirst Submitted
Initial submission to the registry
October 10, 2008
CompletedFirst Posted
Study publicly available on registry
October 13, 2008
CompletedMay 23, 2014
May 1, 2014
7 months
October 10, 2008
May 22, 2014
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
To describe effective use of pain medications, describe demographics, clinical characteristics of patients requiring pain treatments, current treatments, outcomes of treatments and the reasons for changing pain medication during treatment in Taiwan
60 days
Secondary Outcomes (3)
Pain Relief Rating Scale
60 days
Sleeping quality Assessment
60 days
Global Assessments (Patient/Investigator)
60 days
Study Arms (1)
001
Interventions
Eligibility Criteria
Outpatients; Patients must have pain, previously treated with and without medication and have a VAS (Visual analogue scale) score recorded at the enrolment time; Patient must have a VAS score \>4
You may qualify if:
- Outpatients only
- Patients must have pain, previously treated with and without medication and have a VAS (Visual analogue scale) score recorded at the enrolment time
- Patient must have a VAS score \>4
You may not qualify if:
- Patients who are receiving any investigational drug during the study
- Patients with known or suspected psychotic disease or mental retardation.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Johnson & Johnson Taiwan, Ltd. Clinical Trial
Johnson & Johnson Taiwan Ltd
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 10, 2008
First Posted
October 13, 2008
Study Start
October 1, 2007
Primary Completion
May 1, 2008
Study Completion
May 1, 2008
Last Updated
May 23, 2014
Record last verified: 2014-05